000 | 01161 a2200313 4500 | ||
---|---|---|---|
005 | 20250518090653.0 | ||
264 | 0 | _c20210624 | |
008 | 202106s 0 0 eng d | ||
022 | _a1460-2091 | ||
024 | 7 |
_a10.1093/jac/dkaa067 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLeegwater, E | |
245 | 0 | 0 |
_aPopulation pharmacokinetics of ceftriaxone administered as continuous or intermittent infusion in critically ill patients. _h[electronic resource] |
260 |
_bThe Journal of antimicrobial chemotherapy _c06 2020 |
||
300 |
_a1554-1558 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
650 | 0 | 4 | _aCeftriaxone |
650 | 0 | 4 | _aCritical Illness |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 | _aMonte Carlo Method |
700 | 1 | _aKraaijenbrink, B V C | |
700 | 1 | _aMoes, D J A R | |
700 | 1 | _aPurmer, I M | |
700 | 1 | _aWilms, E B | |
773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 75 _gno. 6 _gp. 1554-1558 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/dkaa067 _zAvailable from publisher's website |
999 |
_c30703363 _d30703363 |